1-10 of 10
Leif C. Groop
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Age at Menopause, Reproductive Life Span, and Type 2 Diabetes Risk: Results from the EPIC-InterAct study

Judith S. Brand, MSC, Yvonne T. van der Schouw, PHD, N. Charlotte Onland-Moret, PHD, Stephen J. Sharp, MSC, Ken K. Ong, PHD, Kay-Tee Khaw, PHD, Eva Ardanaz, PHD, Pilar Amiano, PHD, Heiner Boeing, PHD, Maria-Dolores Chirlaque, MD, Françoise Clavel-Chapelon, PHD, Francesca L. Crowe, PHD, Blandine de Lauzon-Guillain, PHD, Eric J. Duell, PHD, Guy Fagherazzi, PHD, Paul W. Franks, PHD, Sara Grioni, MSC, Leif C. Groop, PHD, Rudolf Kaaks, PHD, Timothy J. Key, PHD, Peter M. Nilsson, MD, Kim Overvad, PHD, Domenico Palli, MD, Salvatore Panico, MD, J. Ramón Quirós, MD, Olov Rolandsson, MD, Carlotta Sacerdote, PHD, María-José Sánchez, MD, Nadia Slimani, PHD, Birgit Teucher, PHD, Anne Tjonneland, PHD, Rosario Tumino, MD, Daphne L. van der A, PHD, Edith J.M. Feskens, PHD, Claudia Langenberg, PHD, Nita G. Forouhi, PHD, Elio Riboli, PHD, Nicholas J. Wareham, PHD, The InterAct Consortium
Journal: Diabetes Care
Diabetes Care 2013;36(4):1012–1019
https://doi.org/10.2337/dc12-1020
Published: 14 March 2013
View article titled, Age at Menopause, Reproductive Life Span, and Type 2 Diabetes Risk: <subtitle>Results from the EPIC-InterAct study</subtitle>
Open the PDF for Age at Menopause, Reproductive Life Span, and Type 2 Diabetes Risk: <subtitle>Results from the EPIC-InterAct study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Improved Prandial Glucose Control With Lower Risk of Hypoglycemia With Nateglinide Than With Glibenclamide in Patients With Maturity-Onset Diabetes of the Young Type 3

Tiinamaija Tuomi, MD, PHD, Elina H. Honkanen, MD, Bo Isomaa, MD, Leena Sarelin, RN, Leif C. Groop, MD, PHD
Journal: Diabetes Care
Diabetes Care 2006;29(2):189–194
https://doi.org/10.2337/diacare.29.02.06.dc05-1314
Published: 01 February 2006
View article titled, Improved Prandial Glucose Control With Lower Risk of Hypoglycemia With Nateglinide Than With Glibenclamide in Patients With Maturity-Onset Diabetes of the Young Type 3
Open the PDF for Improved Prandial Glucose Control With Lower Risk of Hypoglycemia With Nateglinide Than With Glibenclamide in Patients With Maturity-Onset Diabetes of the Young Type 3 in another window
Journal Articles

Screening for MODY Mutations, GAD Antibodies, and Type 1 Diabetes– Associated HLA Genotypes in Women With Gestational Diabetes Mellitus

Jianping Weng, MD, PHD, Magnus Ekelund, MD, Markku Lehto, PHD, Haiyan Li, BM, Göran Ekberg, MD, Anders Frid, MD, PHD, Anders Åberg, MD, PHD, Leif C. Groop, MD, PHD, Kerstin Berntorp, MD, PHD
Journal: Diabetes Care
Diabetes Care 2002;25(1):68–71
https://doi.org/10.2337/diacare.25.1.68
Published: 01 January 2002
View article titled, Screening for MODY Mutations, GAD Antibodies, and Type 1 Diabetes– Associated HLA Genotypes in Women With Gestational Diabetes Mellitus
Open the PDF for Screening for MODY Mutations, GAD Antibodies, and Type 1 Diabetes– Associated HLA Genotypes in Women With Gestational Diabetes Mellitus in another window
Journal Articles

GAD Antibodies in NIDDM: Ten-year follow-up from the diagnosis

Leo K Niskanen, MD, Tiinamaija Tuomi, MD, Jukka Karjalainen, MD, Leif C Groop, MD, Matti I J Uusitupa, MD
Journal: Diabetes Care
Diabetes Care 1995;18(12):1557–1565
https://doi.org/10.2337/diacare.18.12.1557
Published: 01 December 1995
View article titled, GAD Antibodies in NIDDM: Ten-year follow-up from the diagnosis
Open the PDF for GAD Antibodies in NIDDM: Ten-year follow-up from the diagnosis in another window
Journal Articles

Morning or Bedtime NPH Insulin Combined With Sulfonylurea in Treatment of NIDDM

Leif C Groop, MD, Elisabeth Widén, MD, Agneta Ekstrand, MD, Carola Saloranta, MD, Anja Franssila-Kallunki, MD, Camilla Schalin-Jäntti, MD, Johan G Eriksson, MD
Journal: Diabetes Care
Diabetes Care 1992;15(7):831–834
https://doi.org/10.2337/diacare.15.7.831
Published: 01 July 1992
View article titled, Morning or Bedtime NPH Insulin Combined With Sulfonylurea in Treatment of NIDDM
Open the PDF for Morning or Bedtime NPH Insulin Combined With Sulfonylurea in Treatment of NIDDM in another window
Journal Articles

Sulfonylureas in NIDDM

Leif C Groop, MD
Journal: Diabetes Care
Diabetes Care 1992;15(6):737–754
https://doi.org/10.2337/diacare.15.6.737
Published: 01 June 1992
View article titled, Sulfonylureas in NIDDM
Open the PDF for Sulfonylureas in NIDDM in another window
Journal Articles

Dose-Dependent Effects of Glyburide on Insulin Secretion and Glucose Uptake in Humans

Leif C Groop, MD, Nir Barzilai, MD, Klaus Ratheiser, MD, Livio Luzi, MD, Elisabeth Wåhlin-Boll, PhD, Arne Melander, MD, Ralph A DeFronzo, MD
Journal: Diabetes Care
Diabetes Care 1991;14(8):724–727
https://doi.org/10.2337/diacare.14.8.724
Published: 01 August 1991
View article titled, Dose-Dependent Effects of Glyburide on Insulin Secretion and Glucose Uptake in Humans
Open the PDF for Dose-Dependent Effects of Glyburide on Insulin Secretion and Glucose Uptake in Humans in another window
Journal Articles

Combined Insulin-Sulfonylurea Therapy in Treatment of NIDDM

Leif C Groop, MD, Per-Henrik Groop, MD, Svante Stenman, MD
Journal: Diabetes Care
Diabetes Care 1990;13(Supplement_3):47–52
https://doi.org/10.2337/diacare.13.3.47
Published: 01 August 1990
View article titled, Combined Insulin-Sulfonylurea Therapy in Treatment of NIDDM
Open the PDF for Combined Insulin-Sulfonylurea Therapy in Treatment of NIDDM in another window
Journal Articles

Do Sulfonylureas Influence Hepatic Insulin Clearance?

Leif C Groop, MD, Per-Henrik Groop, MD, Svante Stenman, MD, Carola Saloranta, MD, Karl-Johan Tötterman, MD, Frej Fyhrquist, MD, Arne Melander, MD
Journal: Diabetes Care
Diabetes Care 1988;11(8):689–690
https://doi.org/10.2337/diacare.11.8.689
Published: 01 September 1988
View article titled, Do Sulfonylureas Influence Hepatic Insulin Clearance?
Open the PDF for Do Sulfonylureas Influence Hepatic Insulin Clearance? in another window
Journal Articles

secondary Failure to Treatment with Oral Antidiabetic Agents in Non-insulin-dependent Diabetes

Leif C Groop, M.D., Risto Pelkonen, M.D., Saija Koskimies, M.D., Gian F Bottazzo, M.R.C.P., Deborah Doniach, F.R.C.P.
Journal: Diabetes Care
Diabetes Care 1986;9(2):129–133
https://doi.org/10.2337/diacare.9.2.129
Published: 01 March 1986
View article titled, secondary Failure to Treatment with Oral Antidiabetic Agents in Non-insulin-dependent Diabetes
Open the PDF for secondary Failure to Treatment with Oral Antidiabetic Agents in Non-insulin-dependent Diabetes in another window